ClostraBio’s world-leading scientific team has made key discoveries that highlight the importance of the intestinal microbiota in regulating allergic sensitization to food. The company is committed to a deeper understanding of the role of intestinal microbes in gut barrier function and determining the mechanisms of barrier protection. ClostraBio is breaking new ground in treatments that restore this protective intestinal barrier function in individuals where it is compromised.